Showing 1 - 10 of 12, total 2 pages [First] [Previous] [ Next] [ Last] |
|
1 | | | pediatric pharmacogenomics ***ection Specification: 1 Detail: The problem of drug safety for newborns and children is very serious. According to data from the Adverse Drug Reaction Monitoring Center of the Ministry of Health of China, the incidence of adverse drug reactions in newborns i... |
|
2 | | | next generation sequencing platform Specification: 1 Detail: NGS Platforms Overview A high-throughput sequencing platform is built around the Bioelectron 4000 gene sequencer, which is supplemented by an automatic nucleic acid preparation system, a gene amplification instrument, and oth... |
|
3 | | | neuromuscular disorders Specification: 1 Detail: Neuromuscular Disorders List Neuromuscular disorders include a wide-range of diseases affecting the peripheral nervous system, which consists of all the motor and sensory nerves that connect the brain and spinal cord to the r... |
|
4 | | | mycobacteria species identification Specification: 1 Detail: Identification of Mycobacterium NTM disease symptoms are strikingly similar to those of MTB disease symptoms, and NTM has an 83.7% insensitivity rate to isoniazid and rifampin, the first-line tuberculosis treatments. The deve... |
|
5 | | | mycobacteria nucleic acid ***ection Specification: 1 Detail: For the purpose of distinguishing between MTB and NTM, the real-time fluorescent PCR and TaqMan probe technologies are utilized. This kit is the only CFDA-approved PCR assay for rapidly separating MTB cases from those caused b... |
|
6 | | | mtb drug resistant ***ection Specification: 1 Detail: The current methods for ***ecting TB drug resistance are inefficient and imprecise, leading to covering drugs that either cause or exacerbate drug resistance. Chromosomal genetic variation is the primary mechanism through whic... |
|
7 | | | karyotype analysis Specification: 1 Detail: The morphological structure and number of chromosomes of the cells to be tested are analyzed to ***ermine whether their karyotype is consistent with the normal karyotype and microarray, which is known as karyotype analysis. Ch... |
|
8 | | | individualized medication guidance for prostate cancer Specification: 1 Detail: This test ***ects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer p... |
|
9 | | | individualized medication guidance for gynecologic cancer Specification: 1 Detail: Gynecologic Cancer Surgery According to the latest Chinese women's new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the wide... |
|
10 | | | individualized medication guidance for gastrointestinal cancer Specification: 1 Detail: This test ***ects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment. Features of Individualized Medication Guidance for Gastrointestinal Cancer ... |
|